Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
5 Potentially Explosive Stocks to Buy in 2023
05:30am, Friday, 13'th Jan 2023
These stocks all dropped in the double digits last year. But their future prospects are brilliant.
Moderna under fire for 400% price hike of COVID vaccine: ‘Outrageous'
12:01pm, Thursday, 12'th Jan 2023
The pharmaceutical giant could raise the price of the vaccine from its current $26 per dose to between $110 and $130 per dose.
Is Moderna Stock A Buy Or A Sell On Lagging Covid Vaccine Sales?
02:02pm, Wednesday, 11'th Jan 2023
Is Moderna stock a buy or a sell after issuing a light preliminary sales outlook for 2022? Is MRNA stock a buy or sell right now?
Moderna considers raising COVID vaccine prices
12:51pm, Wednesday, 11'th Jan 2023
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss reports that Moderna is considering raising the price of its COVID-19 vaccines, Moderna Chairman Noubar Afeyan's response to Senator Ber
Ranking The 10 Largest Biotechs By Pipeline
12:34pm, Wednesday, 11'th Jan 2023
The pipeline is the heart of all drug discovery companies, leading to all growth in the future. As such, understanding the relative strength of a pipeline by comparing to peers can lead to investment
Moderna (MRNA) Reports 2023 Business View & Pipeline Updates
01:32pm, Tuesday, 10'th Jan 2023
Moderna (MRNA) expects to record a minimum of $5 billion in revenues from COVID vaccine sales in 2023. It also expects to incur around $4.5 billion as R&D expenses in 2023.
Moderna mulls Covid vaccine price hike as infections rise
03:29am, Tuesday, 10'th Jan 2023
Moderna Therapeuitics Inc is mulling a hike in the US price of its Covid-19 vaccine to between US$110 to $130 a shot as government contracts come to an end, chief executive Stephane Bancel said in an
Moderna, Inc. (MRNA) 41st Annual J.P. Morgan Healthcare Conference (Transcript)
08:47pm, Monday, 09'th Jan 2023
Moderna, Inc. (NASDAQ:MRNA ) 41st Annual J.P. Morgan Healthcare Conference January 9, 2023 5:15 PM ET Company Participants Stephane Bancel - CEO Conference Call Participants Jessica Fye - J.P Morgan J
WSJ: Moderna may charge up to $130 per dose of its COVID shot
02:52pm, Monday, 09'th Jan 2023
Shares of Moderna Inc. MRNA, +2.39% were up 2.5% in trading on Monday afternoon after the Wall Street Journal reported that the company is considering pricing its COVID-19 vaccine at $110 to $130 per
Moderna Considers Price of $110-$130 for Covid-19 Vaccine
01:40pm, Monday, 09'th Jan 2023
The commercial price for the shot is similar to Pfizer's plans for after government contracting ends.
A flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday, with Moderna telling investors it expects to generate some $5 billion in sales in 2023.
Moderna's COVID shot to generate $5.0 billion in sales in 2023
07:35am, Monday, 09'th Jan 2023
Shares of Moderna Inc. MRNA, +3.94% were up about 1.0% in premarket trading on Monday after the company reiterated that it expects to have $5.0 billion in sales of its COVID-19 vaccine in 2023. Modern
Looking for Growth in 2023? Where to Invest $5,000
06:15am, Saturday, 07'th Jan 2023
Over time, some of last year's losers could win big.
CytomX (CTMX) Up 55% on Strategic Partnership With Moderna
03:03pm, Friday, 06'th Jan 2023
CytomX (CTMX) inks an agreement with Moderna to develop therapeutics for oncology and non-oncology conditions. The company also provides its business outlook for 2023.
CytomX Therapeutics (CTMX) Stock Jumps 50% on Moderna Deal
02:45pm, Friday, 06'th Jan 2023
On a resoundingly positive Friday for the market, CytomX Therapeutics (NASDAQ: CTMX ) is providing a large portion of the fireworks. Specifically, CTMX stock skyrocketed more than 50% before settling
